AI Terminal
Marinomed Biotech AG
Major Shareholding Notification • Sep 26, 2024
749_mrq_2024-09-26_882aeb59-ee44-4a61-a1ff-146544d05869.pdf
Major Shareholding Notification
Open in ViewerOpens in native device viewer
EQS Voting Rights Announcement: Marinomed Biotech AG Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution 26.09.2024 / 09:15 CET/CEST Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018
Wien, 24.9.2024
Overview
☐ Notification made after deadline
Caution: In case of violations of major holdings notification rules, please pay attention to Section 137 BörseG 2018 (Suspension of voting rights)
1. Issuer: Marinomed Biotech AG
2. Reason for the notification: Event changing the breakdown of voting rights
3. Person subject to notification obligation
Name: Österreichische Beamtenversicherung, Versicherungsverein auf Gegenseitigkeit City: 1016 Wien Country: Österreich
4. Name of shareholder(s):
5. Date on which the threshold was crossed or reached: 18.9.2024
6. Total positions
| % of voting rights attached to shares (7.A) |
% of voting rights through financial/other instruments (7.B.1 + 7.B.2) |
Total of both in % (7.A + 7.B) |
Total number of voting rights of issuer |
|
|---|---|---|---|---|
| Resulting situation on the date on which threshold was crossed / reached |
3,71 % | 0,00 % | 3,71 % | 1 694 583 |
| Position of previous notification (if applicable) |
4,08 % |
Details
7. Notified details of the resulting situation:
A: Voting rights attached to shares
| ISIN Code | Number of voting rights | % of voting rights | ||
|---|---|---|---|---|
| Direct (Sec 130 BörseG 2018) |
Indirect (Sec 133 BörseG 2018) |
Direct (Sec 130 BörseG 2018) |
Indirect (Sec 133 BörseG 2018) |
|
| ATMARINOMED6 | 62 916 | 3,71 % | ||
| SUBTOTAL A | 62 916 | 3,71 % |
B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018
| Number of voting | ||||
|---|---|---|---|---|
| Type of | Expiration | Exercise | rights that may be | % of voting |
| instrument Date |
Period | acquired if the | rights | |
| instrument is | ||||
| exercised |
B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018
| Type of | Expiration | Exercise | Physical / | Number of | % of voting |
|---|---|---|---|---|---|
| instrument | Date | Period | Cash | voting | rights |
| Settlement | rights |
SUBTOTAL B.2
8. Information in relation to the person subject to the notification obligation:
☒ Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
☐ Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:
9. In case of proxy voting
Date of general meeting: -
Voting rights after general meeting: - is equivalent to - voting rights.
10. Sonstige Kommentare:
Per 18. September 2024 erfolgte eine 10%ige Kapitalerhöhung des Grundkapitals der Marinomed AG (ATMARINOMED6).
Die Österreichische Beamtenversicherung, Versicherungsverein auf Gegenseitigkeit, hat an dieser Kapitalerhöhung nicht teilgenommen und hält unverändert 62.916 Aktien der Gesellschaft. Ihr Anteil an der Marinomed AG reduzierte sich dadurch von 4,08% auf 3,71%.
Wien am 24.9.2024
26.09.2024 CET/CEST
| Language: | English |
|---|---|
| Company: | Marinomed Biotech AG |
| Hovengasse 25 | |
| 2100 Korneuburg | |
| Austria | |
| Internet: | www.marinomed.com |
End of News EQS News Service